Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer.
Belladelli F, De Cobelli F, Piccolo C, Cei F, Re C, Musso G, Rosiello G, Cignoli D, Santangelo A, Fallara G, Matloob R, Bertini R, Gusmini S, Brembilla G, Lucianò R, Tenace N, Salonia A, Briganti A, Montorsi F, Larcher A, Capitanio U. Belladelli F, et al. Among authors: brembilla g. Urol Oncol. 2024 Nov 7:S1078-1439(24)00700-2. doi: 10.1016/j.urolonc.2024.10.020. Online ahead of print. Urol Oncol. 2024. PMID: 39516081
Less Is More: Enhancing Prostate MRI Without Intravenous Contrast.
Dias AB, Viana PCC, Brembilla G, Giganti F. Dias AB, et al. Among authors: brembilla g. Can Assoc Radiol J. 2024 Oct 16:8465371241291703. doi: 10.1177/08465371241291703. Online ahead of print. Can Assoc Radiol J. 2024. PMID: 39412336 No abstract available.
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.
Mercinelli C, Moschini M, Cigliola A, Mattorre B, Tateo V, Basile G, Cogrossi LL, Maiorano BA, Patanè DA, Raggi D, Pastorino GL, Re C, Colecchia M, Lucianò R, Colombo R, Brembilla G, De Cobelli F, Briganti A, Pavlick DC, Ross JS, Montorsi F, Bellone M, Necchi A. Mercinelli C, et al. Among authors: brembilla g. J Clin Oncol. 2024 Sep 6:JCO2400576. doi: 10.1200/JCO.24.00576. Online ahead of print. J Clin Oncol. 2024. PMID: 39241203
Is MRI ready to replace biopsy during active surveillance?
Dias AB, Woo S, Leni R, Rajwa P, Kasivisvanathan V, Ghai S, Haider M, Gandaglia G, Brembilla G. Dias AB, et al. Among authors: brembilla g. Eur Radiol. 2024 Dec;34(12):7716-7727. doi: 10.1007/s00330-024-10863-9. Epub 2024 Jul 4. Eur Radiol. 2024. PMID: 38965093 Review.
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
Saha A, Bosma JS, Twilt JJ, van Ginneken B, Bjartell A, Padhani AR, Bonekamp D, Villeirs G, Salomon G, Giannarini G, Kalpathy-Cramer J, Barentsz J, Maier-Hein KH, Rusu M, Rouvière O, van den Bergh R, Panebianco V, Kasivisvanathan V, Obuchowski NA, Yakar D, Elschot M, Veltman J, Fütterer JJ, de Rooij M, Huisman H; PI-CAI consortium. Saha A, et al. Lancet Oncol. 2024 Jul;25(7):879-887. doi: 10.1016/S1470-2045(24)00220-1. Epub 2024 Jun 11. Lancet Oncol. 2024. PMID: 38876123 Clinical Trial.
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
Quarta L, Mazzone E, Cannoletta D, Stabile A, Scuderi S, Barletta F, Cucchiara V, Nocera L, Pellegrino A, Robesti D, Leni R, Zaurito P, Brembilla G, De Cobelli F, Samanes Gajate AM, Picchio M, Chiti A, Montorsi F, Briganti A, Gandaglia G. Quarta L, et al. Among authors: brembilla g. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3789-3798. doi: 10.1007/s00259-024-06789-5. Epub 2024 Jun 11. Eur J Nucl Med Mol Imaging. 2024. PMID: 38861182 Free PMC article. Clinical Trial.
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI.
de Rooij M, Allen C, Twilt JJ, Thijssen LCP, Asbach P, Barrett T, Brembilla G, Emberton M, Gupta RT, Haider MA, Kasivisvanathan V, Løgager V, Moore CM, Padhani AR, Panebianco V, Puech P, Purysko AS, Renard-Penna R, Richenberg J, Salomon G, Sanguedolce F, Schoots IG, Thöny HC, Turkbey B, Villeirs G, Walz J, Barentsz J, Giganti F. de Rooij M, et al. Among authors: brembilla g. Eur Radiol. 2024 Nov;34(11):7068-7079. doi: 10.1007/s00330-024-10795-4. Epub 2024 May 24. Eur Radiol. 2024. PMID: 38787428 Free PMC article.
ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESUR.
Ponsiglione A, Brembilla G, Cuocolo R, Gutierrez P, Moreira AS, Pecoraro M, Zawaideh J, Barentsz J, Giganti F, Padhani AR, Panebianco V, Puech P, Villeirs G. Ponsiglione A, et al. Among authors: brembilla g. Eur Radiol. 2024 Nov;34(11):7481-7491. doi: 10.1007/s00330-024-10792-7. Epub 2024 May 23. Eur Radiol. 2024. PMID: 38780764 Free PMC article. Review.
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer.
Cei F, Larcher A, Rosiello G, Basile G, Musso G, Re C, Fallara G, Belladelli F, Brembilla G, Guazzarotti G, De Cobelli F, Marandino L, Necchi A, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U. Cei F, et al. Among authors: brembilla g. Urol Oncol. 2024 Aug;42(8):247.e21-247.e27. doi: 10.1016/j.urolonc.2024.01.029. Epub 2024 Apr 21. Urol Oncol. 2024. PMID: 38644109
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Pellegrino F, Stabile A, Sorce G, Mazzone E, Cannoletta D, Cirulli GO, Quarta L, Leni R, Robesti D, Brembilla G, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Pellegrino F, et al. Among authors: brembilla g. Prostate. 2024 Apr;84(5):473-478. doi: 10.1002/pros.24665. Epub 2023 Dec 27. Prostate. 2024. PMID: 38149793
62 results